Novo Nordisk plans new study for CagriSema, targets 2026 submission
CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...
Psychology Today6h
Ozempic for the Rich, Body Positivity for the Poor
Moreover, the stigma surrounding obesity disproportionately affects lower-income individuals, who are often blamed for their ...
Ozempic Could Get Way Too Expensive Under Trump—Here's What You Can Do
While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.
Pros and cons of weight-loss jabs
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
New Atlas16h
Ozempic is suspected in more cases of sudden vision loss
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
Ozempic, Wegovy and Mounjaro prescribed 11,000 times in Yorkshire - but not for weightloss
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Weight loss drug opportunity is increasingly coming into focus for Indian pharma
Weight loss drugs, which took the US market by storm, are looking to be a big opportunity for drug makers in India. Several ...
MyJoyOnline23h
The New Weight Loss Drugs and the Role of Dietitians in LMICs
Obesity is a growing concern worldwide, including in low- and middle-income countries (LMICs). Addressing this issue involves various strategies, including dietary and lifestyle changes, medical ...